CERRI, SILVIA
CERRI, SILVIA
EX-DIPARTIMENTO DI BIOLOGIA ANIMALE-(1900/2011)
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
2014-01-01 Ambrosi, G.; Cerri, S.; Blandini, F.
Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer
2017-01-01 Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Polimeni, Mariarosa; Tritto, Simona; Fuzzati Armentero, Marie Therese; Bigiani, Albertino; Blandini, Fabio; Mapelli, Lisa; D'Angelo, EGIDIO UGO
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease
2018-01-01 Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease
2018-01-01 Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G.
Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease
2011-01-01 Armentero, M. -T.; Levandis, G.; Bazzini, E.; Cerri, S.; Ghezzi, C.; Blandini, F.
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
2016-01-01 Pellegrini, C.; Fornai, M.; Colucci, R.; Tirotta, E.; Blandini, F.; Levandis, G.; Cerri, S.; Segnani, C.; Ippolito, C.; Bernardini, N.; Cseri, K.; Blandizzi, C.; Hasko, G.; Antonioli, L.
An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease
2020-01-01 Cerri, S.; Blandini, F.
Cell proliferation and death in the brain of active and hibernating frogs
2009-01-01 Cerri, Silvia; Bottiroli, G.; Bottone, MARIA GRAZIA; Barni, Sergio; Bernocchi, Graziella
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat
2017-01-01 Ambrosi, G.; Kustrimovic, N.; Siani, F.; Rasini, E.; Cerri, S.; Ghezzi, C.; Dicorato, G.; Caputo, S.; Marino, F.; Cosentino, M.; Blandini, F.
Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity
2019-01-01 Mus, L.; Siani, F.; Giuliano, C.; Ghezzi, C.; Cerri, S.; Blandini, F.
Developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum
2011-01-01 Cerri, Silvia; Piccolini, VALERIA MARIA; Santin, Giada; Bottone, MARIA GRAZIA; De Pascali, S. A.; Migoni, D.; Iadarola, Paolo; Fanizzi, F. P.; Bernocchi, Graziella
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease
2015-01-01 Fuzzati-Armentero, M. -T.; Cerri, S.; Levandis, G.; Ambrosi, G.; Montepeloso, E.; Antoninetti, G.; Blandini, F.; Baqi, Y.; Muller, C. E.; Volpini, R.; Costa, G.; Simola, N.; Pinna, A.
Effects of cisplatin on neuronal cell B50: involvement of mitochondria in apoptosis induction.
2006-01-01 Avella, Debora; Soldani, Cristiana; Bottone, MARIA GRAZIA; Veneroni, Paola; Pisu Maria, Bonaria; Cerri, Silvia; Bernocchi, Graziella
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
2017-01-01 Pellegrini, C.; Antonioli, L.; Colucci, R.; Tirotta, E.; Gentile, D.; Ippolito, C.; Segnani, C.; Levandis, G.; Cerri, S.; Blandini, F.; Barocelli, E.; Ballabeni, V.; Bernardini, N.; Blandizzi, C.; Fornai, M.
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease
2021-01-01 Cerri, S.; Ghezzi, C.; Ongari, G.; Croce, S.; Avenali, M.; Zangaglia, R.; Di Monte, D. A.; Valente, E. M.; Blandini, F.
Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease
2020-01-01 Milanese, C.; Gabriels, S.; Barnhoorn, S.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Wallace, D. F.; Blandini, F.; Di Monte, D. A.; Subramaniam, V. N.; Mastroberardino, P. G.
Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease
2020-01-01 Avenali, M.; Blandini, F.; Cerri, S.
Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine
2019-01-01 Blandini, F.; Cilia, R.; Cerri, S.; Pezzoli, G.; Schapira, A. H. V.; Mullin, S.; Lanciego, J. L.
Immediate early genes regulation in rat cerebellar cortex during long-term synaptic plasticity induction.
2011-01-01 Polimeni, Mariarosa; Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Tritto, Simona; Alloni, Maurizio; Armentero, M. T.; Blandini, Fabio; D'Angelo, EGIDIO UGO
In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease
2018-01-01 Rizzi, N.; Brunialti, E.; Cerri, S.; Cermisoni, G.; Levandis, G.; Cesari, N.; Maggi, A.; Blandini, F.; Ciana, P.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease | 1-gen-2014 | Ambrosi, G.; Cerri, S.; Blandini, F. | |
| Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer | 1-gen-2017 | Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Polimeni, Mariarosa; Tritto, Simona; Fuzzati Armentero, Marie Therese; Bigiani, Albertino; Blandini, Fabio; Mapelli, Lisa; D'Angelo, EGIDIO UGO | |
| Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease | 1-gen-2018 | Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G. | |
| Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease | 1-gen-2018 | Milanese, C.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Plat, A.; Gabriels, S.; Blandini, F.; Di Monte, D. A.; Hoeijmakers, J. H.; Mastroberardino, P. G. | |
| Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease | 1-gen-2011 | Armentero, M. -T.; Levandis, G.; Bazzini, E.; Cerri, S.; Ghezzi, C.; Blandini, F. | |
| Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration | 1-gen-2016 | Pellegrini, C.; Fornai, M.; Colucci, R.; Tirotta, E.; Blandini, F.; Levandis, G.; Cerri, S.; Segnani, C.; Ippolito, C.; Bernardini, N.; Cseri, K.; Blandizzi, C.; Hasko, G.; Antonioli, L. | |
| An update on the use of non-ergot dopamine agonists for the treatment of Parkinson’s disease | 1-gen-2020 | Cerri, S.; Blandini, F. | |
| Cell proliferation and death in the brain of active and hibernating frogs | 1-gen-2009 | Cerri, Silvia; Bottiroli, G.; Bottone, MARIA GRAZIA; Barni, Sergio; Bernocchi, Graziella | |
| Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat | 1-gen-2017 | Ambrosi, G.; Kustrimovic, N.; Siani, F.; Rasini, E.; Cerri, S.; Ghezzi, C.; Dicorato, G.; Caputo, S.; Marino, F.; Cosentino, M.; Blandini, F. | |
| Development and biochemical characterization of a mouse model of Parkinson's disease bearing defective glucocerebrosidase activity | 1-gen-2019 | Mus, L.; Siani, F.; Giuliano, C.; Ghezzi, C.; Cerri, S.; Blandini, F. | |
| Developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum | 1-gen-2011 | Cerri, Silvia; Piccolini, VALERIA MARIA; Santin, Giada; Bottone, MARIA GRAZIA; De Pascali, S. A.; Migoni, D.; Iadarola, Paolo; Fanizzi, F. P.; Bernocchi, Graziella | |
| Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l -DOPA-induced rotational behavior in a rodent model of Parkinson's disease | 1-gen-2015 | Fuzzati-Armentero, M. -T.; Cerri, S.; Levandis, G.; Ambrosi, G.; Montepeloso, E.; Antoninetti, G.; Blandini, F.; Baqi, Y.; Muller, C. E.; Volpini, R.; Costa, G.; Simola, N.; Pinna, A. | |
| Effects of cisplatin on neuronal cell B50: involvement of mitochondria in apoptosis induction. | 1-gen-2006 | Avella, Debora; Soldani, Cristiana; Bottone, MARIA GRAZIA; Veneroni, Paola; Pisu Maria, Bonaria; Cerri, Silvia; Bernocchi, Graziella | |
| Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration | 1-gen-2017 | Pellegrini, C.; Antonioli, L.; Colucci, R.; Tirotta, E.; Gentile, D.; Ippolito, C.; Segnani, C.; Levandis, G.; Cerri, S.; Blandini, F.; Barocelli, E.; Ballabeni, V.; Bernardini, N.; Blandizzi, C.; Fornai, M. | |
| Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease | 1-gen-2021 | Cerri, S.; Ghezzi, C.; Ongari, G.; Croce, S.; Avenali, M.; Zangaglia, R.; Di Monte, D. A.; Valente, E. M.; Blandini, F. | |
| Gender biased neuroprotective effect of Transferrin Receptor 2 deletion in multiple models of Parkinson’s disease | 1-gen-2020 | Milanese, C.; Gabriels, S.; Barnhoorn, S.; Cerri, S.; Ulusoy, A.; Gornati, S. V.; Wallace, D. F.; Blandini, F.; Di Monte, D. A.; Subramaniam, V. N.; Mastroberardino, P. G. | |
| Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease | 1-gen-2020 | Avenali, M.; Blandini, F.; Cerri, S. | |
| Glucocerebrosidase mutations and synucleinopathies: Toward a model of precision medicine | 1-gen-2019 | Blandini, F.; Cilia, R.; Cerri, S.; Pezzoli, G.; Schapira, A. H. V.; Mullin, S.; Lanciego, J. L. | |
| Immediate early genes regulation in rat cerebellar cortex during long-term synaptic plasticity induction. | 1-gen-2011 | Polimeni, Mariarosa; Gandolfi, Daniela; Cerri, Silvia; Mapelli, Jonathan; Tritto, Simona; Alloni, Maurizio; Armentero, M. T.; Blandini, Fabio; D'Angelo, EGIDIO UGO | |
| In vivo imaging of early signs of dopaminergic neuronal death in an animal model of Parkinson's disease | 1-gen-2018 | Rizzi, N.; Brunialti, E.; Cerri, S.; Cermisoni, G.; Levandis, G.; Cesari, N.; Maggi, A.; Blandini, F.; Ciana, P. |